Goldman Sachs Group Inc Prime Medicine, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 220,144 shares of PRME stock, worth $638,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

220,144

Previous 79,367 177.37%

Holding current value

$638,417

Previous $407,000 109.09%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.41 - $6.7 $480,049 - $943,205	140,777 Added 177.37%	220,144 $851,000
Q2 2024 Aug 13, 2024	BUY	$4.3 - $8.03 $177,104 - $330,731	41,187 Added 107.88%	79,367 $407,000
Q1 2024 May 15, 2024	SELL	$6.35 - $9.39 $82,353 - $121,778	-12,969 Reduced 25.36%	38,180 $267,000
Q4 2023 Feb 13, 2024	SELL	$5.59 - $9.55 $43,389 - $74,127	-7,762 Reduced 13.18%	51,149 $453,000
Q3 2023 May 14, 2024	BUY	$9.5 - $15.07 $73,739 - $116,973	7,762 Added 15.18%	58,911 $562,000
Q3 2023 Nov 14, 2023	BUY	$9.5 - $15.07 $559,654 - $887,788	58,911 New	58,911 $562,000

Others Institutions Holding PRME

# of Institutions

123

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $278M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Prime Medicine, Inc. Transaction History